• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症中三种医生整体评估工具的比较

Comparison of Three Physician Global Assessment Instruments in Systemic Sclerosis.

作者信息

Ross Laura, Hansen Dylan, Proudman Susanna, Walker Jennifer, Kumar Kimti, Stevens Wendy, Ferdowsi Nava, Sahhar Joanne, Ngian Gene-Siew, Apostolopoulos Diane, Host Lauren V, Morrisroe Kathleen, Major Gabor, Baron Murray, Nikpour Mandana

机构信息

The University of Melbourne, Melbourne, and St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.

St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.

出版信息

Arthritis Care Res (Hoboken). 2025 Feb;77(2):251-256. doi: 10.1002/acr.25427. Epub 2024 Oct 9.

DOI:10.1002/acr.25427
PMID:39228047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11771564/
Abstract

OBJECTIVE

Physician global assessments (PhyGAs) are variably applied in systemic sclerosis (SSc) clinical trials. The comparability of different PhyGA results is unknown. We sought to assess the comparability of results from three different PhyGA instruments simultaneously applied in the Australian Scleroderma Cohort Study (ASCS).

METHODS

Using data from 1,965 ASCS participants, we assessed the correlation between results of three PhyGA assessments: (1) overall health, (2) activity, and (3) damage. We evaluated the concordance of change in each PhyGA between study visits. Ordered logistic regression analysis was used to evaluate the clinical associations of each PhyGA.

RESULTS

The absolute scores of each PhyGA were strongly correlated at individual study visits. Concordant changes of the PhyGA scores occurred between 50% of study visits. Only patient-reported breathlessness was associated with all three PhyGA scores (overall health: odds ratio [OR] 1.67, P < 0.01; activity: OR 1.44, P < 0.01; damage: OR 1.32, P < 0.01). Changes in physician-assessed activity scores were also associated with patient-reported worsening skin disease (OR 1.25, P = 0.03) and fecal incontinence (OR 1.23, P = 0.01), whereas damage scores were associated with respiratory disease (pulmonary arterial hypertension: OR 1.25, P = 0.03; chronic obstructive pulmonary disease: OR 1.37, P = 0.04), as well as skin scores (OR 1.02, P < 0.01) and fecal incontinence (OR 1.21, P = 0.02).

CONCLUSION

PhyGAs of overall health, activity, and damage are each associated with different SSc features, and changes in different PhyGA scores are discordant 50% of the time. Our findings suggest results of variably worded PhyGAs are not directly interchangeable and support the development of a standardized PhyGA.

摘要

目的

医师整体评估(PhyGAs)在系统性硬化症(SSc)临床试验中的应用方式各不相同。不同PhyGA结果的可比性尚不清楚。我们试图评估在澳大利亚硬皮病队列研究(ASCS)中同时应用的三种不同PhyGA工具的结果的可比性。

方法

利用1965名ASCS参与者的数据,我们评估了三种PhyGA评估结果之间的相关性:(1)整体健康状况,(2)活动情况,以及(3)损伤情况。我们评估了每次研究访视期间每种PhyGA变化的一致性。采用有序逻辑回归分析来评估每种PhyGA的临床相关性。

结果

在各个研究访视中,每种PhyGA的绝对分数都高度相关。50%的研究访视期间出现了PhyGA分数的一致变化。仅患者报告的呼吸急促与所有三种PhyGA分数相关(整体健康状况:比值比[OR]1.67,P<0.01;活动情况:OR 1.44,P<0.01;损伤情况:OR 1.32,P<0.01)。医师评估的活动分数变化也与患者报告的皮肤病加重(OR 1.25,P = 0.03)和大便失禁(OR 1.23,P = 0.01)相关,而损伤分数与呼吸系统疾病(肺动脉高压:OR 1.25,P = 0.03;慢性阻塞性肺疾病:OR 1.37,P = 0.04)以及皮肤分数(OR 1.02,P<0.01)和大便失禁(OR 1.21,P = 0.02)相关。

结论

整体健康状况、活动情况和损伤情况的PhyGAs分别与不同的SSc特征相关,并且不同PhyGA分数的变化在50%的时间内不一致。我们的研究结果表明,措辞不同的PhyGAs结果不能直接互换,并支持开发标准化的PhyGA。

相似文献

1
Comparison of Three Physician Global Assessment Instruments in Systemic Sclerosis.系统性硬化症中三种医生整体评估工具的比较
Arthritis Care Res (Hoboken). 2025 Feb;77(2):251-256. doi: 10.1002/acr.25427. Epub 2024 Oct 9.
2
Evaluation of Patient and Physician Assessments of Gastrointestinal Disease Activity in Systemic Sclerosis.系统性硬化症患者及医生对胃肠道疾病活动度评估的研究
J Rheumatol. 2023 Apr;50(4):519-525. doi: 10.3899/jrheum.220832. Epub 2022 Nov 15.
3
The role of inflammatory markers in assessment of disease activity in systemic sclerosis.炎症标志物在系统性硬化症疾病活动评估中的作用。
Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):126-134. Epub 2018 Sep 29.
4
Contribution of Left Ventricular Diastolic Dysfunction to Survival and Breathlessness in Systemic Sclerosis-Associated Interstitial Lung Disease.左心室舒张功能障碍对系统性硬化症相关间质性肺病患者生存和呼吸困难的影响。
J Rheumatol. 2024 May 1;51(5):495-504. doi: 10.3899/jrheum.2023-0801.
5
Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.C 反应蛋白与系统性硬化症高疾病活动度的相关性:来自加拿大硬皮病研究组的研究结果。
Arthritis Care Res (Hoboken). 2012 Sep;64(9):1405-14. doi: 10.1002/acr.21716.
6
Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item Health Profile and Functional Assessment of Chronic Illness Therapy-Dyspnea short form.两种新的系统性硬化症患者报告结局测量工具的有效性:患者报告结局测量信息系统 29 项健康概况和慢性疾病治疗呼吸困难简短形式的功能评估。
Arthritis Care Res (Hoboken). 2011 Nov;63(11):1620-8. doi: 10.1002/acr.20591.
7
Can Patient-Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?患者报告的症状能否用于衡量系统性硬化症的疾病活动度?
Arthritis Care Res (Hoboken). 2020 Oct;72(10):1459-1465. doi: 10.1002/acr.24053.
8
Investigating the trajectory of functional disability in systemic sclerosis: group-based trajectory modelling of the Health Assessment Questionnaire-Disability Index.探讨系统性硬化症患者功能残疾轨迹:健康评估问卷残疾指数的基于群组轨迹建模分析。
Clin Exp Rheumatol. 2024 Aug;42(8):1581-1589. doi: 10.55563/clinexprheumatol/9erk5j. Epub 2024 Aug 2.
9
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.系统性硬化症合并活动性肺泡炎患者呼吸困难程度与健康相关生活质量、功能能力及一氧化碳弥散能力的相关性:硬皮病肺部研究结果
Arthritis Rheum. 2005 Feb;52(2):592-600. doi: 10.1002/art.20787.
10
Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis.简单血液学参数与系统性硬化症患者疾病表现、活动度和严重程度的相关性。
Clin Rheumatol. 2020 Jan;39(1):77-83. doi: 10.1007/s10067-019-04685-0. Epub 2019 Jul 18.

本文引用的文献

1
Composite measures to assess disease damage, disease severity and treatment response in systemic sclerosis clinical trials.系统性硬化症临床试验中评估疾病损害、疾病严重程度及治疗反应的综合指标。
Curr Opin Rheumatol. 2023 Nov 1;35(6):334-340. doi: 10.1097/BOR.0000000000000971. Epub 2023 Aug 29.
2
Systemic sclerosis.系统性硬化症。
Lancet. 2023 Jan 28;401(10373):304-318. doi: 10.1016/S0140-6736(22)01692-0. Epub 2022 Nov 25.
3
Patient and Physician Global Assessments of Disease Status in Systemic Sclerosis.系统性硬化症患者和医生对疾病状况的全球评估。
Arthritis Care Res (Hoboken). 2023 Jul;75(7):1443-1451. doi: 10.1002/acr.25056. Epub 2023 Jan 6.
4
Low back pain.下背痛。
Lancet. 2021 Jul 3;398(10294):78-92. doi: 10.1016/S0140-6736(21)00733-9. Epub 2021 Jun 8.
5
Depression.抑郁症。
Ann Intern Med. 2021 May;174(5):ITC65-ITC80. doi: 10.7326/AITC202105180. Epub 2021 May 11.
6
Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review.髋关节和膝关节骨关节炎的诊断与治疗:综述
JAMA. 2021 Feb 9;325(6):568-578. doi: 10.1001/jama.2020.22171.
7
New composite endpoint in early diffuse cutaneous systemic sclerosis: revisiting the provisional American College of Rheumatology Composite Response Index in Systemic Sclerosis.早期弥漫性皮肤系统性硬化症的新综合终点:重新审视美国风湿病学会系统性硬化症综合反应指数的暂定标准。
Ann Rheum Dis. 2021 May;80(5):641-650. doi: 10.1136/annrheumdis-2020-219100. Epub 2020 Nov 30.
8
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.美国风湿病学会早期弥漫性皮肤系统性硬化症临床试验的临时综合反应指数。
Arthritis Rheumatol. 2016 Feb;68(2):299-311. doi: 10.1002/art.39501.
9
Assessment of dyspnea early in acute heart failure: patient characteristics and response differences between likert and visual analog scales.急性心力衰竭早期呼吸困难的评估:患者特征以及李克特量表与视觉模拟量表之间的反应差异
Acad Emerg Med. 2014 Jun;21(6):659-66. doi: 10.1111/acem.12390.
10
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.2013 年系统性硬化症分类标准:美国风湿病学会/欧洲抗风湿病联盟合作倡议。
Ann Rheum Dis. 2013 Nov;72(11):1747-55. doi: 10.1136/annrheumdis-2013-204424.